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Nanomaterials have been actively pursued as new molecular probes for biomedical imaging.
1 The vast majority of nano-sized imaging probes are based on purely inorganic materials such
as quantum dots,2 superparamagnetic metal oxides,3 and gold nanoparticles or nanoshells.4
Metal-organic frameworks (MOFs) are a new class of hybrid materials built from metal ions
with well-defined coordination geometry and organic bridging ligands which have already
shown promise in a number of applications including catalysis,5 nonlinear optics,6 and gas
storage.7 In contrast to inorganic materials, the compositions and structures of MOFs are
innumerable owing to the choice of a vast range of metal ions and organic linkers. We thus
envision that new multimodal imaging probes can be designed by incorporating suitable metal
ions and organic moieties into nanoscale metal-organic frameworks (NMOFs).
Although there is an extensive literature on the synthesis and characterization of bulk MOF
materials, few reports have appeared on NMOFs.8 Wang et al. synthesized submicrometer-
scale spherical colloids of the Pt(p-phenylenediamine) system by simply mixing the metal and
organic components in aqueous solution,8a whereas Mirkin et al. prepared spherical particles
of a zinc MOF via precipitation induced by a poor solvent.8b These methods are however not
applicable to other metal-ligand combinations, and the amorphous nature of the resulting
colloid particles prohibits a detailed understanding of these systems. Herein we wish to report
a general water-in-oil microemulsion-based methodology for the synthesis of NMOFs and their
preliminary evaluation as multimodal imaging probes.
Gd(BDC)1.5(H2O)2 (1) nanorods (where BDC is 1,4-benzenedicarboxylate) were prepared by
stirring an optically transparent microemulsion of GdCl3 and bis(methylammonium)-
benzene-1,4-dicarboxylate (in a 2:3 molar ratio) in the cationic cetyltrimethylammonium
bromide (CTAB)/isooctane/1-hexanol/water system for 2 h. The nanorods of 1 were isolated
in 84% yield by centrifugation and washing with ethanol and water. Scanning electron
micrographic (SEM) images of 1 demonstrated the formation of nanorods of fairly uniform
shape and size (Fig 1). The morphologies and sizes of the nanorods were influenced by the
w value (defined as the water/surfactant molar ratio) of the microemulsion systems. For
example, nanorods of 1 of 100 to 125 nm in length by 40 nm in diameter were obtained with
w=5 and a Gd3+ concentration of 50 mM. As the w value was increased to 10, nanorods of 1
one to two μm in length and ∼100 nm in diameter were obtained under otherwise identical
conditions. We have carried out numerous syntheses and have observed very consistent
morphologies and sizes for nanorods of 1 under identical conditions. The particle size of 1 was
also affected by the reactant concentration and the reactant ratio. A decrease in the
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concentration of reactants or a deviation of the metal to ligand molar ratio from 2:3 typically
resulted in a decrease of the particle size. Powder X-ray diffraction (PXRD) studies showed
that the nanorods of 1 were crystalline and had the same diffraction pattern as the bulk phase
of Tb(BDC)1.5(H2O)2.9 The composition of 1 was further supported by thermogravimetric
analysis which showed that 1 lost the two coordinated water molecules in the 125 to 140 °C
range.
To probe the generality of NMOF synthesis in reverse microemulsions, we have carried out
reactions of GdCl3 and tri(methylammonium)benzene-1,2,4-tricarboxylate (1,2,4-BTC) in the
CTAB/isooctane/1-hexanol/water microemulsion system. As shown in Fig 2, irregularly-
shaped, crystalline nanoplates of [Gd(1,2,4-BTC)(H2O)3]•H2O, 2, with a diameter of ∼100 nm
and an average thickness of 35 nm were successfully synthesized with a w value of 15. The
identity and phase purity of the nanoplates of 2 were also confirmed by PXRD and TGA results
(supporting info).10 Although reverse microemulsions have been successfully used for the
synthesis of a range of nanomaterials including organic polymers, semiconductors, and metal
oxides, these are the first examples of NMOF syntheses in reverse microemulsions.
The presence of the Gd3+ centers in 1 and 2 has prompted us to examine their utility as nanoscale
contrast agents for magnetic resonance imaging (MRI). MRI is a powerful noninvasive medical
diagnostic technique that can differentiate normal tissues from diseased tissues based on their
varied NMR water proton signals arising from different water densities and/or nuclear
relaxation rates.11 Complexes of highly paramagnetic metal ions such as Gd3+ are often
administered to enhance the image contrast by increasing water proton relaxation rates.
Currently available metal chelate-based contrast agents however exhibit modest longitudinal
(R1) relaxivities and large quantities (several grams per patient) must be administered to
provide adequate MR contrast. We rationalize that 1 and 2 NMOFs contain a large number of
Gd3+ centers and would therefore give very large relaxivities on a per particle basis. When
conjugated to targeting moieties, such nanomaterials can be effective site-specific MR contrast
agents owing to their large metal payload.
Relaxivity data obtained with suspensions of 1 in water containing 0.1% xanthan gum showed
that nanorods of 1 of ∼100 nm in length and ∼40 nm in diameter (with ∼4.5×105 Gd3+/nanorod)
had an R1 value of 35.8 s−1 per mM of Gd3+ and ∼1.6×107 s−1 per mM of nanorod. 1 also
exhibited a transverse relaxivity (R2) of 55.6 s−1 per mM Gd3+ and ∼2.5×107 s−1 per mM of
nanorod. This level of R1 relaxivity is unprecedented and at least an order of magnitude higher
than those of Gd3+-containing liposomes which have been shown to be effective target-specific
MR contrast agents for cancer and cardiovascular disease.12 Nanorods of 1 of ∼400 nm in
length by ∼70 nm in diameter (with ∼7.4×106 Gd3+/nanorod) had an R1 value of 26.9 s−1 per
mM Gd3+ and ∼2.0×108 s−1 per mM nanorod as well as an R2 of 49.1 s−1 per mM Gd3+ and
∼3.6×108 s−1 per mM of nanorod. A further increase in particle size to ∼1 μm in length and
∼100 nm in diameter (∼5.6×107 Gd3+/nanorod) resulted in an R1 of 20.1 s−1 per mM Gd3+
and ∼1.1×109 s−1 per mM nanorod and an R2 of 45.7 s−1 per mM Gd3+ and ∼2.6×109 s−1 per
mM of nanorod. The inverse size dependence of per mM Gd3+ relaxivity observed for 1 is
consistent with the decreasing surface to volume ratio for the larger nanorods. We believe that
the Gd3+ centers at or near the surface are primarily responsible for the observed relaxivities.
We also measured the relaxivities of nanoplates of 2 of a diameter of ∼100 nm and an average
thickness of 35 nm which exhibited an R1 of 13.0 s−1 per mM Gd3+ and ∼3.25×107 s−1 per
mM nanoplate (with ∼2.5×106 Gd3+/nanoplate) and an R2 of 29.4 s−1 per mM Gd3+ and
∼7.35×107 s−1 per mM of nanoplate.
As shown in Fig 3c, nanorods of 1 are much more efficient in enhancing the water signals in
T1-weighted images than clinically used OmniScan. Interestingly however, very significant
signal reduction was caused by nanorods of 1 in T2-weigthed images (supporting information)
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when a spin-echo pulse sequence was used. The very high R1 and R2 relaxivities exhibited by
1 and 2 thus allow their use as both T1- and T2-contrast agents depending on the MR pulse
sequence employed.
We have also successfully synthesized luminescent nanorods of 1 by using Eu3+ or Tb3+
dopants. By mixing in 5 mol% of EuNO3 or TbNO3 during the syntheses, nanorods of similar
sizes and morphologies to 1 were obtained and had the compositions of
Gd0.95(BDC)1.5(H2O)2:Eu0.05 (1a) and Gd0.95(BDC)1.5(H2O)2:Tb0.05 (1b). Ethanol
dispersions of these doped nanorods are highly luminescent upon UV excitation with
characteristic red and green luminescence from Eu3+ and Tb3+, respectively (Fig 3d). These
results suggest that NMOFs such as 1 can be used as potential contrast agents for multimodal
imaging.
In summary, we have developed a general reverse microemulsion-based methodology for the
synthesis of NMOFs. These NMOFs exhibit large R1 and R2 relaxivities on a per mM of
Gd3+ basis and extraordinarily large R1 and R2 relaxivities on a per mM of nanoparticle basis.
Doping of luminescent lanthanide ions was also demonstrated. Molecular targeting of such
NMOFs to biomarkers that are associated with certain diseased cells should be feasible to
potentially lead to a new class of target-specific multimodal imaging contrast agents.
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SEM images of Gd(BDC)1.5(H2O)2 (1) nanorods synthesized with w=5 (left) and w=10 (right).
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SEM images of irregularly-shaped, crystalline [Gd(1,2,4-BTC)(H2O)3]•H2O (2) nanoplates.
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(a) R1 and R2 relaxivity curves of 1 of ∼100 nm in length by ∼40 nm in diameter. (b) R1 and
R2 relaxivity curves of 1 of ∼1 μm in length by ∼100 nm in diameter. In comparison, OmniScan
gave an R1 of 4.1 mM−1•s−1 under these conditions. (c) T1-weighted MR images of
suspensions of 1 in water containing 0.1% xanthan gum. (d) Luminescence images of ethanolic
suspensions of 1, 1a (1 doped with 5 mol% Eu3+), and 1b (1 doped with 5 mol% Tb3+).
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